Lineage Cell Therapeutics Inc logo

Lineage Cell Therapeutics Inc

FRA:BT3 (USA)  
€ 0.78 (-3.73%) Oct 8
At Loss
P/B:
2.40
Market Cap:
€ 149.37M ($ 163.63M)
Enterprise V:
€ 117.00M ($ 128.17M)
Volume:
17.00
Avg Vol (2M):
2.74K
Trade In:
Volume:
17.00
At Loss

Lineage Cell Therapeutics Inc Valuation Measures